berisa Posted September 9, 2003 Share Posted September 9, 2003 Aventis says Taxotere helps fight early lung cancer Thu August 14, 2003 03:25 AM ET In PARIS story headlined "Aventis says Taxotere helps fight early lung cancer" please read in first paragraph ...Franco-German... instead of ...Franco-American... (correcting nationality) A corrected version follows: PARIS, Aug 14 (Reuters) - Franco-German drug maker Aventis AVEP.PA said on Thursday recent studies showed its Taxotere drug was beneficial in initial chemotherapy to fight non-small cell lung cancer. A French Phase II study showed a doubling of the three year survival rate when Taxotere was administered with chemotherapy agent cisplatin followed by cancer-fighting drug vinorelbine versus a dose of cisplatin and vinorelbine followed by Taxotere, Aventis said. A German Phase II study showed a median survival rate of 8.5 months compared with 6.2 months when Taxotere was administered before gemcitabine as opposed to afterwards in advanced non-small cell lung cancer, Aventis said. A third study showed elderly patients with advanced non-small lung cancer who received Taxotere with a platinum compound had an improved median survival compared to a combined dose of vinorelbine and cisplatin, Aventis said. The studies were presented at the 10th World Lung Conference in Vancouver, Canada Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.